PULM Stock Financial Analysis - Pulmatrix, Inc. (NasdaqCM) Stock

Overview

Pulmatrix, Inc., based in the United States, operates within the biotechnology sector focusing on the development of innovative inhaled therapies to address severe respiratory diseases using its patented iSPERSE technology. This technology enhances the delivery of drugs directly to the lungs by producing uniquely dense, small particles that are efficient in penetrating deep into the lung tissue. Pulmatrix's key project pipeline primarily targets conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory ailments. The company is particularly noted for its innovative approach to respiratory care, aiming to improve patient outcomes and reduce systemic side effects by maximally utilizing localized delivery mechanisms. This strategic focus aligns with its broader mission to advance pulmonary disease treatment through breakthrough therapies.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Pulmatrix, Inc. as of June 30, 2025 is 0.37 MM.
The operating income for Pulmatrix, Inc. as of June 30, 2025 is -8.00 MM.
The net income for Pulmatrix, Inc. as of June 30, 2025 is -7.93 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	0.37	-8.00	-7.93
2025-03-31	1.92	-9.74	-12.19
2024-12-31	7.81	-7.14	-9.56
2024-09-30	10.01	-7.42	-9.66
2024-06-30	11.39	-8.70	-10.84
2024-03-31	11.68	-9.41	-8.85
2023-12-31	7.30	-14.74	-14.12
2023-09-30	6.80	-16.84	-16.25
2023-06-30	6.92	-18.00	-17.53
2023-03-31	6.41	-18.57	-18.31
2022-12-31	6.07	-18.95	-18.84
2022-09-30	4.82	-18.66	-18.65
2022-06-30	4.02	-18.18	-21.78
2022-03-31	4.94	-17.47	-21.04
2021-12-31	5.17	-16.59	-20.17
2021-09-30	6.71	-15.22	-19.04
2021-06-30	10.02	-11.88	-21.41
2021-03-31	11.26	-9.21	-18.73
2020-12-31	12.63	-9.86	-19.31
2020-09-30	12.32	-11.30	-20.45
2020-06-30

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31	-3.34	-3.34
2024-12-31	-2.62
2024-09-30	-2.64	-2.64
2024-06-30	-2.97	-2.97
2024-03-31	-2.42	-2.42
2023-12-31	-3.87
2023-09-30	-4.45	-4.45
2023-06-30	-4.86	-4.86
2023-03-31	-5.18	-5.18
2022-12-31	-5.46
2022-09-30	-6.71	-6.71
2022-06-30	-8.08	-8.08
2022-03-31	-8.20	-8.20
2021-12-31	-8.63
2021-09-30	-7.79	-7.79
2021-06-30	-9.91	-9.91
2021-03-31	-10.66	-10.66
2020-12-31	-13.43
2020-09-30	-16.49	-16.49
2020-06-30	-12.58	-12.58

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Pulmatrix, Inc. as of June 30, 2025 is -8.02 MM.
The cash from investing activities for Pulmatrix, Inc. as of June 30, 2025 is 0.00 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	-8.02	0.00
2025-03-31	-9.81	-0.24
2024-12-31	-10.72	-0.40
2024-09-30	-11.47	-0.70	0.00
2024-06-30	-12.55	-1.02	0.00
2024-03-31	-13.78	-0.83	0.00
2023-12-31	-15.98	-0.68	0.05
2023-09-30	-19.02	-0.38	0.05
2023-06-30	-18.48	-0.07	1.44
2023-03-31	-18.14	-0.08	1.44
2022-12-31	-19.36	-0.09	1.23
2022-09-30	-18.71	-0.10	7.42
2022-06-30	-18.41	-0.20	6.04
2022-03-31	-20.38	-0.15	6.04
2021-12-31	-19.73	-0.14	43.48
2021-09-30	-18.10	-0.20	37.28
2021-06-30	-20.30	-0.20	50.15
2021-03-31	-18.78	-0.18	58.00
2020-12-31	-12.48	-0.28	20.98
2020-09-30	-14.15	-0.21	20.98
2020-06-30

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/book for Pulmatrix, Inc. as of June 30, 2025 is 3.53.
The p/tbv for Pulmatrix, Inc. as of June 30, 2025 is 3.53.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30		3.53	3.53
2025-03-31		2.94	2.94
2024-12-31		2.29	2.29
2024-09-30	-0.72	0.59	0.59
2024-06-30	-0.80	0.37	0.37
2024-03-31		0.30	0.30
2023-12-31	-0.42	0.34	0.34
2023-09-30	-0.42	0.32	0.32
2023-06-30	-0.54	0.37	0.37
2023-03-31	-0.56	0.34
2022-12-31		0.40	0.40
2022-09-30		0.32	0.32
2022-06-30		0.36	0.36
2022-03-31	-1.10	0.47	0.47
2021-12-31	-1.28	0.54	0.59
2021-09-30	-2.10	0.85	0.91
2021-06-30
2021-03-31	-0.84	0.28	0.30
2020-12-31	-10.47	8.74	10.34
2020-09-30	-0.47	0.41	0.48
2020-06-30	-0.54	0.52	0.70

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Pulmatrix, Inc. as of June 30, 2025 is -0.70.
The ebit (3y)/ev for Pulmatrix, Inc. as of June 30, 2025 is -0.77.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	-0.70	-0.77
2025-03-31	-0.57	-0.73
2024-12-31	-0.68	-1.00
2024-09-30	2.38	3.34
2024-06-30	0.96	1.74
2024-03-31	1.06	1.20
2023-12-31	1.12	1.24
2023-09-30	0.95	1.10
2023-06-30	0.88	0.98
2023-03-31	0.75	0.78
2022-12-31	0.70	0.73
2022-09-30	0.71	0.66
2022-06-30	0.66	0.59
2022-03-31	0.66	0.64
2021-12-31	0.65	0.67
2021-09-30	1.80	1.76
2021-06-30
2021-03-31	0.39	0.41
2020-12-31	-0.11	-0.12
2020-09-30	0.82	0.83
2020-06-30	0.67	0.93

Management Effectiveness

The roa for Pulmatrix, Inc. as of June 30, 2025 is -0.77.
The roe for Pulmatrix, Inc. as of June 30, 2025 is -0.92.
The roic for Pulmatrix, Inc. as of June 30, 2025 is -1.71.
The croic for Pulmatrix, Inc. as of June 30, 2025 is -1.41.
The ocroic for Pulmatrix, Inc. as of June 30, 2025 is -1.37.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	-0.77	-0.92	-1.71	-1.41	-1.37
2025-03-31	-0.31	-0.50	-1.07	-1.24	-1.20
2024-12-31	-0.28	-0.54	-0.88	-1.11	-1.05
2024-09-30	-0.29	-0.55	-0.50	-0.63	-0.58
2024-06-30	-0.25	-0.33	-0.32	-0.53	-0.50
2024-03-31	-0.40	-0.52	-0.57	-0.68	-0.67
2023-12-31	-0.35	-0.46	-0.57	-0.68	-0.67
2023-09-30	-0.35	-0.46	-0.74	-0.72	-0.78
2023-06-30	-0.37	-0.48	-0.74	-0.72	-0.78
2023-03-31	-0.35	-0.44	-0.66	-0.60	-0.65
2022-12-31	-0.33	-0.41	-0.51	-0.31	-0.51
2022-09-30	-0.39	-0.48	-0.51	-0.31	-0.51
2022-06-30	-0.32	-0.40	-0.54	-0.31	-0.45
2022-03-31	-0.29	-0.36	-0.47	-0.32	-0.46
2021-12-31	-0.50	-0.82	-0.41	0.47	-0.39
2021-09-30	-0.44	-0.91	-0.41	0.41	-0.37
2021-06-30	-0.61	-1.54	-0.39	0.54	-0.37
2021-03-31	-0.61	-2.70	-0.32	0.67	-0.32
2020-12-31	-0.53	-1.75	-0.78	0.33	-0.50
2020-09-30	-0.62	-1.39	-0.81	0.26	-0.56
2020-06-30	-0.36	-0.74	-0.84	-0.29	-0.79

Gross Margins

The gross margin for Pulmatrix, Inc. as of June 30, 2025 is 0.98.
The net margin for Pulmatrix, Inc. as of June 30, 2025 is -6.35.
The operating margin for Pulmatrix, Inc. as of June 30, 2025 is -5.07.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.98	-6.35	-5.07
2025-03-31	0.98	-1.22	-0.92
2024-12-31	-0.07	-0.97	-0.74
2024-09-30	-0.21	-0.95	-0.99
2024-06-30	-0.63	-0.76	-0.81
2024-03-31	-1.42	-2.39	-2.48
2023-12-31	-1.42	-2.39	-2.48
2023-09-30	-1.57	-2.53	-2.60
2023-06-30	-1.80	-2.53	-2.60
2023-03-31	1.00	-2.86	-2.90
2022-12-31	0.72	-3.87	-3.87
2022-09-30	0.98	-3.87	-3.87
2022-06-30	0.94	-5.42	-4.53
2022-03-31	1.00	-4.26	-3.54
2021-12-31	-1.34	-3.90	-3.21
2021-09-30	-0.55	-2.84	-2.27
2021-06-30	-0.55	-2.14	-1.19
2021-03-31	-0.26	-1.66	-0.82
2020-12-31	-0.24	-1.53	-0.78
2020-09-30	-0.34	-1.66	-0.92
2020-06-30	-0.71	-1.44	-1.46